SScience Read More CRATERs identified as key sites for T cell-mediated tumor destructionOctober 18, 2025 Like the surface of the moon, new research published today in Cell finds the existence of craters on…
GGenetics Read More Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseasesOctober 1, 2025 Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare…
HHealth Read More The neurological complexity of Mamba snake venoms uncoveredOctober 1, 2025 A breakthrough study at The University of Queensland has discovered a hidden dangerous feature in the Black Mamba…
HHealth Read More Controversy surrounding Covid-19 vaccination during pregnancySeptember 30, 2025 Whether or not those who are pregnant should take a Covid-19 vaccine to protect themselves and their infants…
HHealth Read More Hypnosis improves patient comfort and outcomes for acute respiratory failureSeptember 29, 2025 Hypnosis can significantly improve patients’ tolerance of masks to help them breathe when they are suffering from acute…
HHealth Read More Precision probiotics lower blood sugar and cholesterol in miceSeptember 29, 2025 A new mouse study reveals that carefully selected probiotics can lower blood sugar, body fat, and cholesterol levels…
HHealth Read More Brain shunt surgery improves walking and quality of life in older adults with hydrocephalusSeptember 16, 2025 Implanting a brain shunt in older people diagnosed with idiopathic normal pressure hydrocephalus (iNPH) is effective in improving…
GGenetics Read More Genetic study shows dual GIPR/GLP1R action curbs binge alcohol useSeptember 15, 2025 New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
HHealth Read More Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulantsSeptember 1, 2025 Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
HHealth Read More Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factorsSeptember 1, 2025 Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
HHealth Read More Novel monoclonal antibodies show promise in preventing severe mpox diseaseAugust 26, 2025 A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three…
HHealth Read More How a single gene reshapes pain perception through polyamine signalingAugust 25, 2025 A breakthrough discovery reveals how the SLC45A4 gene fine-tunes polyamine transport in sensory neurons, reshaping our understanding of…